Rheumatoid Arthritis Clinical Trials in Chicago

Showing 461-480 of 3,348 trials

A Study of CTD402 in T-ALL/LBL Patients

NCT07070219

The goal of the TENACITY-01 clinical trial is to learn if CTD402 UCART is safe and effective for relapsed/refractory T-ALL/LBL patients. Participants with relapsed/refractory T-ALL/LBL over the age of 12 will be eligible to participate. Participants will receive one infusion of CTD402 on Day 0 and will be evaluated for anti-tumor activity by an independent review committee based on the NCCN criteria for T-ALL and the Lugano 2014 criteria for T-LBL. Patients will be followed for up to 24 months in this study and will be required to enroll under a separate long term follow up protocol to be followed for up to 15 years.

Acute Lymphocytic Leukemia RefractoryLymphoma, Lymphoblastic

BIOHENG THERAPEUTICS US LLC54 participantsStarted Oct 2025

Palo Alto, California, United States • Denver, Colorado, United States • Chicago, Illinois, United States +5 more locations

Active Not RecruitingNA2.2 miles

Aventus Thrombectomy System Pulmonary Embolism Clinical Study

NCT05907564

Evaluate the safety and efficacy of the Aventus Thrombectomy System for aspiration thrombectomy in subjects with acute pulmonary embolism.

Pulmonary EmbolismEmbolismEmbolism and Thrombosis+4 more

Inquis Medical, Inc.130 participantsStarted Sep 2023

Scottsdale, Arizona, United States • Fairfield, California, United States • Long Beach, California, United States +23 more locations

A Study of CTD402 in T-ALL/LBL Patients

Aventus Thrombectomy System Pulmonary Embolism Clinical Study

Rheumatoid Arthritis Trials in Other Cities

Posterior Rectus Sheath Hiatal Augmentation in Paraesophageal Hernia Repair

COMPASSION S3 Post-Approval Study

A Phase IIb Randomized, Multicenter Trial of Subretinal CPCB-RPE1 in Advanced Dry AMD (Geographic Atrophy)

HLA-Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation With Reduced Dose Post Transplantation Cyclophosphamide GvHD Prophylaxis

Micra AV Transcatheter Pacing System Post-Approval Registry

A Study of LY3540378 in Participants With Worsening Chronic Heart Failure With Preserved Ejection Fraction (HFpEF)

A Study of MGC026 in Participants With Advanced Solid Tumors

64Cu-SAR-bisPSMA and 67Cu-SAR-bisPSMA for Identification and Treatment of PSMA-expressing Metastatic Castrate Resistant Prostate Cancer (SECuRE)

Study of Alpha Radioligand Therapy AB001 in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC)

Neonatal Seizure Registry - Developmental Functional EValuation

A Study of AAV2-hAQP1 Gene Therapy in Participants With Radiation-Induced Late Xerostomia

Usnoflast Neuromuscular Investigation for Treatment Efficacy in Amyotrophic Lateral Sclerosis

Study of Axicabtagene Ciloleucel Given With Steroids In Participants With Relapsed Or Refractory Large B-Cell Lymphoma

Safety, Tolerability, Efficacy and Pharmacokinetics of Imipenem/Cilastatin/Relebactam (MK-7655A) in Pediatric Participants With Gram-negative Bacterial Infection (MK-7655A-021)

A Pilot Study to Evidence Improved Cranial Flap Fixation With a Bioresorbable Bone Adhesive

HYDRAFIL-D: HYDRogel Augmentation For Intervertebral Lumbar Discs

Study to Assess Safety, Efficacy, and Cellular Kinetics of YTB323 in Generalized Myasthenia Gravis

International Registry Study of Neutral Lipid Storage Disease (NLSD) / Triglyceride Deposit Cardiomyovasculopathy (TGCV) and Related Diseases

Other Conditions in Chicago